Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Six years ago, new cocktails of anti-HIV drugs transformed prospects for infected people in industrialized countries. Now, serious limitations have become apparent, including numerous long-term drug side effects and a rise in transmission of drug-resistant strains of HIV. As researchers prepare to gather in Barcelona, Spain, next week for the XIV International AIDS Conference, this special package looks at two pressing issues on the agenda: problems limiting the effectiveness of current treatments and puzzles over what kinds of immune responses might lead to vaccines.
The editors suggest the following Related Resources on Science sites:
In Science Magazine
LETTERS
George M. Carter, Richard Elion, Mark Kuebel, Janet Mindes, Devan Nambiar, Jane Shull, Vince Silenzio, and Jackie Wootton (23 August 2002) Science297 (5585), 1276a.
[DOI: 10.1126/science.297.5585.1276a] |Full Text »|PDF »
EDITORIAL
David Baltimore (28 June 2002) Science296 (5577), 2297.
[DOI: 10.1126/science.296.5577.2297] |Summary »|PDF »
POLICY FORUM
Joan Kaufman and Jun Jing (28 June 2002) Science296 (5577), 2339.
[DOI: 10.1126/science.1074479] |Summary »|Full Text »|PDF »
REVIEW
Brian Gaschen, Jesse Taylor, Karina Yusim, Brian Foley, Feng Gao, Dorothy Lang, Vladimir Novitsky, Barton Haynes, Beatrice H. Hahn, Tanmoy Bhattacharya, and Bette Korber (28 June 2002) Science296 (5577), 2354.
[DOI: 10.1126/science.1070441] |Abstract »|Full Text »|PDF »|Supplemental Data »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Viral Suppression and Immune Restoration in the Gastrointestinal Mucosa of Human Immunodeficiency Virus Type 1-Infected Patients Initiating Therapy during Primary or Chronic Infection..
M. Guadalupe, S. Sankaran, M. D. George, E. Reay, D. Verhoeven, B. L. Shacklett, J. Flamm, J. Wegelin, T. Prindiville, and S. Dandekar (2006)
J. Virol.
80, 8236-8247
|Abstract »|Full Text »|PDF »
Antiretroviral Drugs for Tuberculosis Control in the Era of HIV/AIDS.
